Peritoneal metastases in colorectal cancer
R Jacobson, SK Sherman, F Dadaleh… - Annals of surgical …, 2018 - Springer
R Jacobson, SK Sherman, F Dadaleh, KK Turaga
Annals of surgical oncology, 2018•SpringerIn the late 20th century, patients and physicians tended to view peritoneal metastases from
colorectal cancer (CRC-PM) with significant nihilism. While surgical cytoreduction emerged
as an important adjunct to systemic chemotherapy in the treatment of liver and lung
oligometastases, the adoption of surgery for peritoneal metastases has lagged. This review
highlights the epidemiology of peritoneal metastases, current treatment guidelines, and their
relationship to recent evidence and ongoing trials in surgical and adjuvant therapy.
colorectal cancer (CRC-PM) with significant nihilism. While surgical cytoreduction emerged
as an important adjunct to systemic chemotherapy in the treatment of liver and lung
oligometastases, the adoption of surgery for peritoneal metastases has lagged. This review
highlights the epidemiology of peritoneal metastases, current treatment guidelines, and their
relationship to recent evidence and ongoing trials in surgical and adjuvant therapy.
In the late 20th century, patients and physicians tended to view peritoneal metastases from colorectal cancer (CRC-PM) with significant nihilism. While surgical cytoreduction emerged as an important adjunct to systemic chemotherapy in the treatment of liver and lung oligometastases, the adoption of surgery for peritoneal metastases has lagged. This review highlights the epidemiology of peritoneal metastases, current treatment guidelines, and their relationship to recent evidence and ongoing trials in surgical and adjuvant therapy.
Springer